-
1 Comment
Mayinglong Pharmaceutical Group Co., LTD is currently in a long term uptrend where the price is trading 26.0% above its 200 day moving average.
From a valuation standpoint, the stock is 70.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.8.
Mayinglong Pharmaceutical Group Co., LTD's total revenue rose by 35.0% to $1B since the same quarter in the previous year.
Its net income has increased by 34.2% to $90M since the same quarter in the previous year.
Finally, its free cash flow fell by 118.6% to $-65M since the same quarter in the previous year.
Based on the above factors, Mayinglong Pharmaceutical Group Co., LTD gets an overall score of 4/5.
| CurrencyCode | CNY |
|---|---|
| ISIN | CNE000001HN2 |
| Exchange | SHG |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Dividend Yield | 2.1% |
|---|---|
| Beta | 0.43 |
| Market Cap | 12B |
| PE Ratio | 20.77 |
| Target Price | 20.45 |
Mayinglong Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells Chinese and Western medicines in China and internationally. The company offers functional cosmetics, functional care products and food, Chinese herbal medicines, and medical devices. It also manufactures, processes, and sells medicinal packaging materials, cosmetics, and Chinese medicines; and offers first and second category medical devices, household products, electronic products, daily necessities, hygiene products, and disinfection products, as well as automobile freight services. In addition, the company is involved in the retail and wholesale of medical devices and medicines; provision of hospital and medical management service; and hospital operations. Further, it imports raw and auxiliary materials, machinery and equipment, instruments and meters, spare parts and related technologies; and exports its products. Mayinglong Pharmaceutical Group Co., Ltd. was founded in 1582 and is headquartered in Wuhan, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600993.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
